Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
10.65
-0.18 (-1.66%)
Nov 10, 2026, 10:33 AM EST - Market open
Sagimet Biosciences Employees
Sagimet Biosciences had 16 employees as of December 31, 2025. The number of employees increased by 2 or 14.29% compared to the previous year. That makes Sagimet Biosciences the 39,050th largest employer in the world and 5,691st in the United States.
Employees
16
Change (1Y)
2
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,942,438
Market Cap
755.18M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | 2 | 14.29% | 16 | 0 |
| Dec 31, 2024 | 14 | 4 | 40.00% | 14 | 0 |
| Dec 31, 2023 | 10 | 0 | - | 8 | 2 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 9 | 1 |
| Dec 31, 2020 | 7 | - | - | 6 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Rigel Pharmaceuticals | 174 |
| Prime Medicine | 146 |
| Solid Biosciences | 121 |
| Aura Biosciences | 113 |
| Cullinan Therapeutics | 109 |
| OmniAb | 89 |
| Immix Biopharma | 21 |
SGMT News
- 1 day ago - Sagimet Biosciences Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 12 days ago - Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - Sagimet announces dosing of first patient in AURORA study - TheFly
- 19 days ago - H.C. Wainwright views Sagimet dosing news as ‘incrementally positive’ - TheFly
- 19 days ago - Sagimet Biosciences Announces First Patient Dosed in AURORA Phase 3 U.S. Clinical Trial of Denifanstat for Moderate to Severe Acne - GlobeNewsWire
- 4 weeks ago - Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference - GlobeNewsWire
- 5 weeks ago - Sagimet Biosciences price target raised to $26 from $25 at Guggenheim - TheFly
- 5 weeks ago - Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants - GlobeNewsWire